DALLAS, Jul. 31, 2015 /PRNewswire-iReach/ -- From 2001,
FMD, HPAI, PRRS and Swine were respectively been included in
compulsory immunity vaccines, meanwhile, China's animal vaccine industry experienced a
rapid development with a CAGR of 19.2 from 2000 to 2014. Currently
the market size of China's animal
vaccine industry has exceeded RMB 9
billion, which mainly formed up by pig and poultry vaccines
with a respectively market share of 49% and 40% in 2014.
Complete report on the china animal vaccine industry
spread across 142 pages is now available at
http://www.reportsnreports.com/reports/406773-research-on-china-animal-vaccine-industry-2015.html.
Photo -
http://photos.prnewswire.com/prnh/20150730/250289LOGO
FMD Vaccine：
Currently there are only 7 enterprises received the official
approval, including one that has not yet been put into production.
CAHIC accounts for the largest share of the relatively stable
governmental tender vaccine. For market-oriented vaccine, products
from Jinyu Group are always in the state that lags behind
demand.
HPAI Vaccine:
Currently there are 9 enterprises in this segment, HPAI sales
would most probably exceed RMB 2
billion in 2015. Suspension cultivation will be the most
promising direction in HPAI vaccine. Liaoning Yikang Biological
Corporation Limited is the leading domestic enterprise in
suspension cultivation.
Place a direct purchase order of this report at
http://www.reportsnreports.com/purchase.aspx?name=406773.
PRRS Vaccine:
Porcine reproductive and respiratory syndrome would most
probably no longer been an option of compulsory immunity in the
near future. The existing inactivated and activated vaccines are
still controversial nowadays. Gene engineering vaccine may achieve
the break in this segment.
PCV Vaccine:
As the largest part of conventional vaccines, PCV came into
market in 2010 with high price and low market penetration rate till
now. China PCV market is led by Boehringer Ingelheim. Domestic
enterprises such as Jinyu Group are now successively publishing
relative gene engineering vaccines.
Swine Vaccine:
The tender price continuously decreasing and will be the first
to be removed from compulsory immunity lists.
Table of Contents
1. Analysis of Animal Vaccine Industry
1.1 International Animal Vaccine Industry
1.1.1 Market Size
1.1.2 Market Structure
1.1.3 Competition Pattern
1.1.4 New Diseases and New Products
1.2 Chinese Animal Vaccine Industry
1.2.1 Market Size
1.2.2 Market Structure
1.2.3 Import & Export
1.2.4 Profit Level
1.2.5 Entry Barriers
1.2.6 Competition Pattern
2. Development Environment of China Animal Vaccine
Industry
2.1 Policy
2.1.1 Major Policies
2.1.2 Compulsory Immunization Vaccine Tender System
2.2 Social Environment
2.2.1 Breeding Industry is Developing Steadily
2.2.2 Large-scale Breeding Becomes a Trend
2.2.3 Animal Epidemics Occur Frequently
3. Prospects of China Animal Vaccine Industry
3.1 Overall Forecast
3.2 Swine Vaccine
3.2.1 Swine Fever Vaccine
3.2.2 FMD Vaccine
3.2.3 PRRS Vaccine
3.2.4 Porcine Circovirus Vaccine
3.3 Poultry Vaccine
3.4 Cattle & Sheep Vaccine
3.5 Pet Vaccine
4. Major Companies
4.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)
4.1.1 Company Profile
4.1.2 Revenue Structure
4.1.3 Key Financial Data
4.1.5 Animal Vaccine Business
4.2 Inner Mongolia Jinyu Group Stock Company
4.2.1 Company Profile
4.2.2 Revenue Structure
4.2.3 Key Financial Data
4.2.4 R&D
4.2.5 Animal Vaccine Business
4.3 Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
4.3.1 Company Profile
4.3.2 Revenue Structure
4.3.3 Key Financial Data
4.3.4 R&D
4.3.5 Clients & Suppliers
4.3.6 Animal Vaccine Business
4.4 Ningbo TECH-BANK Co., Ltd.
4.4.1 Company Profile
4.4.2 Revenue Structure
4.4.3 Key Financial Data
4.4.4 R&D
4.4.6 Animal Vaccine Business
4.5 Zhejiang Shenghua Biok Biology Co., Ltd.
4.5.1 Company Profile
4.5.2 Revenue Structure
4.5.3 Key Financial Data
4.5.4 Clients
4.5.6 Animal Vaccine Business
4.6 Chengdu Huasun Group Inc. Ltd.
4.6.1 Company Profile
4.6.2 Revenue Structure
4.6.3 Key Financial Data
4.6.4 Clients & Suppliers
4.6.5 Animal Vaccine Business
4.7 Tianjin Ringpu Bio-technology Co., Ltd.
4.7.1 Company Profile
4.7.2 Revenue Structure
4.7.3 Key Financial Data
4.7.4 R&D
4.7.5 Animal Vaccine Business
4.8 Guangdong Dahuanong Animal Health Products Co., Ltd. (DHN)
4.8.1 Company Profile
4.8.2 Revenue Structure
4.8.3 Key Financial Data
4.8.4 R&D
4.8.5 Animal Vaccine Business
4.9 Liaoning Yikang Biological Corporation Limited
4.9.1 Company Profile
4.9.2 Revenue Structure
4.9.3 Key Financial Data
4.9.4 R&D
4.9.5 Clients & Suppliers
4.9.6 Animal Vaccine Business
4.10 Wuhan Chopper Biology Co., Ltd.
4.10.1 Company Profile
4.10.2 Revenue Structure
4.10.3 Key Financial Data
4.10.4 R&D
4.10.5 Clients & Suppliers
4.10.6 Animal Vaccine Business
4.11 Shanghai HILE Bio-Technology Co., Ltd.
4.11.1 Company Profile
4.11.2 Revenue Structure
4.11.3 Key Financial Data
4.11.4 R&D
4.11.5 Clients & Suppliers
4.11.6 Animal Vaccine Business
Browse more reports on PharmaceuticalsMarket at
http://www.reportsnreports.com/market-research/pharmaceuticals/.
About Us:
ReportsnReports.com (http://www.reportsnreports.com/) is an
online database of market research reports offers in-depth analysis
of over 5000 market segments. The library has syndicated reports by
leading market research publishers across the globe and also offer
customized market research reports for multiple industries. Contact
sales@reportsandreports.com for further information.
Media Contact: Ritesh
Tiwari, ReportsnReports, + 1 888 391 5441,
sales@reportsandreports.com
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE ReportsnReports